This antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma / leukemia, and interdigitating dendritic cell sarcoma of the lymph node. Anti-CD1a Antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa).
SDS-PAGE analysis of Anti-CD1a Antibody [CB-T6] under non-reduced and reduced conditions; showing intact IgG and intact heavy and light chains, respectively. SDS-PAGE analysis confirms the integrity and purity of the antibody.